A drug called ataluren is in phase 3 testing, after showing mixed results in earlier studies. Its maker, PTC Therapeutics Inc., declined to comment because it has filed to go public. Pfizer Inc. says it is in phase 1 testing of an antibody that aims to ...
BY WORLD DRUG TRACKER
DR ANTHONY MELVIN CRASTO
No comments:
Post a Comment